Ma, Yunfeng <br/><br/>
Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection.  [electronic resource] 

 -  Microbes and infection  Nov 2011 
 - 1099-110 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1769-714X 
<br/><br/><label>Standard No.: </label>10.1016/j.micinf.2011.06.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--blood<br/>Adult<br/>Animals<br/>Female<br/>Humans<br/>Immunotherapy<br/>Interferon-gamma--blood<br/>Interleukins--blood<br/>Leukocytes, Mononuclear--immunology<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Muscles--microbiology<br/>Mycobacterium tuberculosis--immunology<br/>Neutrophils--immunology<br/>Rabbits<br/>Receptors, Interleukin--metabolism<br/>Recombinant Fusion Proteins--pharmacology<br/>Signal Transduction<br/>Spleen--microbiology<br/>Tuberculosis--immunology